CClinicalTrials.gg
RecruitingNCT06852209CITRINeSUpdated Apr 2, 2025

Training Cognition With Neurofeedback After Stroke

An interventional study of Cognitive remediation therapy and Neuropsychological assessment in Stroke and Cognitive Impairment, sponsored by University Hospital, Bordeaux. Recruiting at 1 site in France. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-04-02.

Sponsored by University Hospital, Bordeaux · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Feb 2025; still recruiting 1 year 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Post-stroke cognitive impairment (PSCI) is a common source of invisible disability. The actual techniques of cognitive remediation have been reported to have only a small effect, justifying the need to foster research in this field. Real-time functional MRI neurofeedack (rt-fMRI NF) is a procedure of brain-machine interface supporting self-regulation of brain activity, with promising results in the treatment of mental disorders. The main objective of the study is to evaluate in a pilot study, the ability of stroke patients to learn to self-regulate their brain activity in a priviledged direction, using rt-fMRI NF

Read the detailed description

Stroke is a major source of cognitive impairment including slowdown of processing speed, executive functions disturbances, attention and memory loss, that can lead to invisible disability, even before the ultimate stage of dementia. The traditional techniques of cognitive remediation have been reported to have a small effect, and european scientific societies stated on the need to foster research in the field of PSCI, with the goal of preventing cognitive decline. PSCI mechanisms arising from functional MRI studies include a disconnexion of brain networks, with a loss of segregation between networks and integration within networks, centered on the frontoparietal network. Rt-fMRI NF is a psychophysiological procedure of brain-machine interface enabling to a subject to learn to self-regulate his brain activity in a desired direction, based on the brain haemodynamic response. Promising results in the treatment of mental disorders have been reported using rt-fMRI NF, but data are scarce in the field of cognitive rehabilitation after stroke. Based on the mechanisms of PSCI reported in fMRI studies, the goal of the present study is to evaluate the ability of stroke patients to learn to self-regulate a brain target using rt-fMRI NF. The brain target is defined by the difference of activation between the central executive network (CEN, or frontoparietal network) and the default mode network (DMN), known to be highly anticorrelated with the CEN in the healthy brain. The experimental procedure will include four training sessions of rt-fMRI NF (1/week), preceded by a localizer session for the identification of the target networks, and followed by a tranfer session where the subjects will be asked to try to self-regulate their brain activity but without receiving feedback. A control group will perform the four fMRI sessions but without receiving feedback. The two groups will receive cognitive remediation therapy as treatment as usual. Resting state scans and diffusion tensor imaging seqences will be performed before and after the intervention, to measure the changes in functional and structural connectivity. A neuropsychological assessment will be also performed before and after the intervention, to measure the changes in cognitive performances.

02

Conditions studied

  • Stroke
  • Cognitive Impairment

Keywords

  • Stroke
  • Cognition
  • Real time-fMRI
  • Neurofeedback
03

In context

Stroke

7,287 studies on the registry are indexed under Stroke; 2,006 are open to participants now.

This study's planned enrollment of 20 is below the median of 50 across 5,370 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

University Hospital, Bordeaux is the lead sponsor of 783 studies on the registry; 188 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Men or women
  • Right handed
  • 18 ≤ years old \< 75
  • first-ever ischemic stroke on brain MRI in the past 3 to 6 months ;
  • Persisting cognitive complaint 3 months after the ischemic stroke, proved by a MoCA score ≤ 26 (if educational level ≥ 12 years, or ≤ 25 if educational level \< 12 years), and involving at least one of the following cognitive domains : executive functions, attention, and processing speed ;
  • Ischemic stroke located in the territory of the middle cerebral artery and /or basal ganglia/thalamus ;
  • NIHSS ≤ 5, without aphasia or severe visual disability empeding the understanding of the instructions, the neurofeedback task achievement, and/or the neuropsychological assessment ;
  • No prestroke disability defined by a modified Rankin Scale ≤ 2 ;
  • For women of childbearing potential, use of effective contraception and negative pregnancy test.
  • Written informed consent by the patient.
  • Coverage by the French Social Insurance

Exclusion criteria

Exclusion Criteria:

  • Previous cognitive impairment ;
  • History of psychiatric disorder ;
  • Current use of psychotropic medication ;
  • MRI contraindication ;
  • Pregnancy or breastfeeding ;
  • Chronic disease empeding the follow-up of the subject during the lenght of the study ;
  • Non fluently-French speakers ;
  • Patient under legal protection.
  • Patient unable of giving personal consent
  • Emergency situation
  • 1st MRI incomplete, not performed or not analyzable
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Experimental group

    Training sessions of rt-fMRI NF. The experimental procedure will include four training sessions of rt-fMRI NF (1/week), preceded by a localizer session for the identification of the target networks, and followed by a tranfer session where the subjects will be asked to try to self-regulate their brain activity but without receiving feedback

    Procedure: Cognitive remediation therapy · Procedure: Neuropsychological assessment · Procedure: Real-time functional MRI neurofeedack (rt-fMRI NF)

  • Active comparator
    Control group

    Four fMRI sessions but without receiving feedback

    Procedure: Cognitive remediation therapy · Procedure: Neuropsychological assessment · Procedure: fMRI sessions

Interventions

  • ProcedureCognitive remediation therapy

    Cognitive remediation therapy as treatment as usual

  • ProcedureNeuropsychological assessment

    Neuropsychological assessment to measure cognitive performances

  • ProcedureReal-time functional MRI neurofeedack (rt-fMRI NF)

    Real-time functional MRI neurofeedack (rt-fMRI NF) is a procedure of brain-machine interface supporting self-regulation of brain activity, with promising results in the treatment of mental disorders. The main objective of the study is to evaluate in a pilot study, the ability of stroke patients to learn to self-regulate their brain activity in a priviledged direction.

  • ProcedurefMRI sessions

    fMRI sessions but without receiving feedback

06

What researchers measure

Primary outcomes

  1. Differential CEN-DMN activity and imaging contrast between regulation and rest

    Change from baseline to each training session on the CEN-DMN activity during regulation compared with rest, in the experimental and control groups

    Time frame: Through study training completion, an average of 4 weeks

Secondary outcomes

  1. Evolution of global cognition assessed by the Montreal Cognitive Assessment (MoCA)

    Change from baseline to the end of the study on the MoCA score. The MoCA score allows the detection of mild cognitive impairment and is ranged from 0 (minimum) to 30 (maximum : no cognitive impairment).

    Time frame: Through study completion, an average of 6 weeks

  2. Evolution of executive functions assessed by a composite score

    Change from baseline to the end of the study on a composite Z-score made from the averages of the Z-scores of the following tests : * verbal fluency : the subject is asked to cite a maximum of animals, letters starting with the letter P and V in 60 seconds) ; * memory span (working memory) : the subject is asked to restitute a maximum of the items of a list immediatly after hearing them) ; * Trail making Test (cognitive flexibility) : the subject is asked to link a set of digits in increasing order, alternating with letters, or items of different shapes or colors, the number of errors is recorded ; * Stroop task (inhibition capacity) : the subject is asked to name the font color of a list of words of colors which don't match their font color ; * Zoo testing plan (scheduling ability) : the subject is asked to follow a list of instructions for the visit of a zoo, while dealing with a list of constraints.

    Time frame: through study completion, an average of 6 weeks

  3. Evolution of attentional functions assessed by the Mesulam cancellation task

    Change from baseline to the end of the study on the Mesulam cancellation task : the subject is asked to cancel a specific target among random arrays of structured and unstructured verbal and nonverbal stimuli.

    Time frame: Through study completion, an average of 6weeks

  4. Evolution of processing speed assessed by the Symbol Digit Modalities Test (SDMT)

    Change from baseline to the end of the study on the SDMT : the subject is provided with a set of symbols corresponding to numbers, and he is asked to write the symbols corresponding to a specific list of numbers in 5 minutes.

    Time frame: Through study completion, an average of 6 weeks

  5. Evolution of memory functions assessed by the 16-item Free and Cued Recall

    Change from baseline to the end of the study on the 16-item Free and Cued Recall : the subject is asked to recall a set of 16 words presented by 4, immediately and after an interfering task, the number of free and cued correct recalls are recorded.

    Time frame: Through study completion, an average of 6 weeks

  6. Evolution of visuospatial functions assessed by the Rey figure

    Change from baseline to the end of the study on the Rey figure : the subject is asked to copy a complex figure as quickly as possible, and then, to reproduce the figure without the model.

    Time frame: Through study completion, an average of 6 weeks

  7. Evolution of language functions assessed byt the 40-item neuropsychological semantic battery

    Change from baseline to the end of the study on the 40-item neuropsychological semantic battery : the subject is asked to name a set of 40 living and non living items in verbal and visual conditions, across 6 subtests of matching.

    Time frame: Through study completion, an average of 6 weeks

  8. Evolution of the Central Executive Network (CEN) activity

    Change from baseline to each training session in the CEN activity recorded in the CEN mask during regulation compared with rest, in the experimental and control groups. The CEN mask is a binary mask individualized after running a pipeline for each subject, and the functional activity into this mask is extracted to assess the specific trajectory of the CEN activity.

    Time frame: Through study training completion, an average of 4 weeks

  9. Evolution of the Default Mode Network (DMN) activity

    Change from baseline to each training session in the DMN activity recorded in the DMN mask during regulation compared with rest, in the experimental and control groups. The DMN mask is a binary mask individualized after running a pipeline for each subject, and the functional activity into this mask is extracted to assess the specific trajectory of DMN activity.

    Time frame: Through study training completion, an average of 4 weeks

  10. Evolution of activity in the whole brain

    Change from baseline to each training session on the whole brain activity during regulation compared with rest, in the experimental and control groups

    Time frame: Through study training completion, an average of 4 weeks

  11. Evolution of resting state CEN and DMN activity

    Change in correlation between resting state CEN and DMN activity before intervention compared with after intervention.

    Time frame: Through study completion, an average of 6 weeks

  12. Microstructural changes assessed by Fractional Anisotropy (FA)

    Change in median FA parameters before intervention compared with after intervention

    Time frame: Through study completion, an average of 6 weeks

  13. Microstructural changes assessed by Mean Diffusivity (MD)

    Change in median MD parameters (mm2/sec) before intervention compared with after intervention

    Time frame: Through study completion, an average of 6 weeks

  14. Microstructural changes assessed by Axial Diffusivity (AD)

    Change in median AD parameters (mm2/sec) before intervention compared with after intervention

    Time frame: Through study completion, an average of 6 weeks

  15. Microstructural changes assessed by Radial Diffusivity (RD)

    Change in median RD parameters (mm2/sec) before intervention compared with after intervention

    Time frame: Through study completion, an average of 6 weeks

  16. Differential CEN-DMN activity and imaging contrast between regulation and rest, without neurofeedback

    Change from baseline to the last fMRI session (" transfert session " without neurofeedback) on the CEN-DMN activity during regulation compared with rest, in the experimental and control groups

    Time frame: Through study completion, an average of 6 weeks

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06852209
Lead sponsor
University Hospital, Bordeaux
Responsible party
Sponsor
First posted
Feb 28, 2025
Start date
Feb 28, 2025
Primary completion
Oct 28, 2026 (estimated)
Completion
Nov 28, 2026 (estimated)
Last update
Apr 2, 2025

Study contacts

Sharmila SAGNIER, Dr
Contact
sharmila.sagnier@chu-bordeaux.fr
05 56 79 55 20
Sharmila SAGNIER
principal investigator · University Hospital, Bordeaux

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion